Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more) Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Healthcare Biotechnology
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care... see more

Recent & Breaking News (TSXV:COV)

Covalon Delays Filing of Interim Financial Statements Due to Delays Related to COVID-19 and Provides Business Update

Canada NewsWire May 29, 2020

Amir Boloor Joins Covalon's Board of Directors

Business Wire April 27, 2020

Martin Goldfarb, O.C., Joins Covalon's Board of Directors

Business Wire April 23, 2020

Covalon Postpones Annual Meeting of Shareholders Due to COVID-19

Business Wire April 14, 2020

Covalon Announces Conference Call to Discuss New CovaGuard Antimicrobial Technology

Business Wire April 3, 2020

IIROC Trading Resumption - COV

Canada NewsWire April 1, 2020

Covalon Clarifies Previous Press Release

Business Wire March 31, 2020

IIROC Trading Halt - COV

Canada NewsWire March 31, 2020

Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus

Business Wire March 31, 2020

Covalon Announces First Quarter Fiscal 2020 Results

Business Wire March 2, 2020

Covalon Announces Conference Call to Discuss First Quarter Financial Results

Business Wire February 28, 2020

Covalon Announces Fiscal 2019 Year-End Results and Plans for Fiscal 2020

Business Wire January 28, 2020

Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter Financial Results

Business Wire January 27, 2020

Covalon Announces Closing of Non-Brokered Private Placement

Business Wire September 18, 2019

Covalon Announces Re-Pricing of Private Placement

Business Wire September 6, 2019

Covalon Announces Third Quarter Fiscal 2019 Results

Business Wire August 27, 2019

Covalon Announces Private Placement of Up To $6.3 Million

Business Wire August 1, 2019

Covalon CEO Provides Corporate Update

Business Wire July 25, 2019

Covalon Announces Second Quarter Fiscal 2019 Results

Business Wire May 28, 2019

Covalon Announces Conference Call to Discuss Second Quarter Financial Results

Business Wire May 27, 2019